Core Viewpoint - Wanfu Bio has been dedicated to the in vitro diagnostic field for 30 years, responding to the health needs for hepatitis prevention and treatment by launching over 10 hepatitis detection products, covering various types of hepatitis and liver cancer [1] Group 1: Company Overview - Wanfu Bio has developed a comprehensive testing solution for hepatitis prevention and treatment, including products for hepatitis A, B, C, D, and liver cancer [1] - The company utilizes platforms such as colloidal gold, immunofluorescence, and chemiluminescence for its diagnostic products [1] Group 2: Industry Impact - The "Spark Plan" is being promoted in Guangdong and nationwide, aiming to enhance hepatitis screening and prevention efforts across a broader region [1] - The innovative outcomes from the "Spark Plan" are expected to provide strong support for hepatitis screening and prevention in more areas [1]

Core Viewpoint - The World Health Organization (WHO) emphasizes the importance of combating hepatitis with available vaccines and effective treatments, aiming for the public health elimination of hepatitis threats by 2030 [1][2] Group 1: Hepatitis Overview - Viral hepatitis is an inflammation of the liver, categorized into five types: A, B, C, D, and E, which can lead to severe liver diseases and even liver cancer [1] - In 2022, there were 304 million people globally suffering from chronic hepatitis B and C, resulting in 1.3 million deaths, primarily due to liver cancer and cirrhosis [1] - Daily, there are approximately 6,000 new infections of hepatitis B and C worldwide [1] Group 2: Prevention and Treatment Recommendations - WHO recommends public screening for hepatitis B and C, vaccination of newborns within 24 hours of birth, and education on hepatitis knowledge to encourage early detection and treatment [1][2] - The World Hepatitis Alliance suggests providing safe drinking water, proper sewage management, and promoting hygiene practices to prevent hepatitis A and E [2] - WHO advises integrating hepatitis care with liver cancer prevention efforts and expanding affordable testing and treatment services [2]

Core Insights - Hepatitis is a significant public health issue affecting human health, with various types including viral hepatitis, alcoholic liver disease, and metabolic liver diseases [1][2] Group 1: Types of Hepatitis - Viral hepatitis primarily refers to hepatitis A, B, and C, but other factors such as alcohol, metabolism, immunity, drugs, chemicals, and parasites can also cause liver inflammation [1] - Hepatitis A and E are generally self-limiting and do not progress to chronic conditions, while certain populations like pregnant women and chronic liver disease patients may experience severe outcomes [1] - Hepatitis C can be effectively cured with direct-acting antiviral (DAA) treatments, achieving a cure rate for nearly all patients within 8-12 weeks, even in advanced stages [1] Group 2: Treatment and Management - Hepatitis B currently cannot be completely cured, and most patients require long-term antiviral therapy to control viral replication [2] - Some patients with hepatitis B may achieve functional cure with long-acting interferon, but those with decompensated cirrhosis cannot use this treatment and need ongoing management [2] Group 3: Prevention Strategies - Regular screening and health check-ups are essential for early detection and treatment of viral hepatitis to prevent transmission [4] - Vaccination is the most effective method to prevent hepatitis B, while hepatitis C prevention focuses on avoiding blood exposure and practicing safe behaviors [4] - Maintaining a healthy diet, controlling weight, and reducing liver burden are crucial for liver health [4] - Avoiding excessive alcohol consumption is important as it can lead to liver cell damage and increased liver function indicators [4] - Caution is advised with medication use, as many drugs can be toxic to the liver, and patients should follow medical advice to avoid liver damage [4]